Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—To investigate the association of retinopathy with the risk of all-cause, cardiovascular disease (CVD), and coronary heart disease (CHD) mortality in type 2 diabetic subjects in a population-based 18-year follow-up study with particular emphasis on sex differences. RESEARCH DESIGN AND METHODS—Our study cohort comprised 425 Finnish type 2 diabetic men and 399 type 2 diabetic women who were free of CVD at baseline. The findings were classified based on standardized clinical ophthalmoscopy to categories of no retinopathy, background retinopathy, and proliferative retinopathy. The study end points were all-cause, CVD, and CHD mortality. RESULTS—Adjusted Cox model hazard ratios (95% CIs) of all-cause, CVD, and CHD mortality in men were 1.34 (0.98–1.83), 1.30 (0.86–1.96), and 1.18 (0.74–1.89), respectively, for background retinopathy and 3.05 (1.70–5.45), 3.32 (1.61–6.78), and 2.54 (1.07–6.04), respectively, for proliferative retinopathy and in women 1.61 (1.17–2.22), 1.71 (1.17–2.51), and 1.79 (1.13–2.85), respectively, for background retinopathy and 2.92 (1.41–6.06), 3.17 (1.38–7.30), and 4.98 (2.06–12.06), respectively, for proliferative retinopathy. CONCLUSIONS—Proliferative retinopathy in both sexes and background retinopathy in women predicted all-cause, CVD, and CHD death. These associations were independent of current smoking, hypertension, total cholesterol, HDL cholesterol, glycemic control of diabetes, duration of diabetes, and proteinuria. This suggests the presence of common background pathways for diabetic microvascular and macrovascular disease other than those included in the conventional risk assessment of CVD. The sex difference observed in the association of background retinopathy with macrovascular disease warrants closer examination.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetic retinopathy is the main cause of blindness in developed countries and is associated with increased CV mortality ( 129 , 147 ).”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [129]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Stratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019
Barger, A. C., Beeuwkes, R., Lainey, L. L., & Silverman, K. J. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401193100307 · Cited by 849
Wong, T. Y., Klein, R., Sharrett, A. R., Duncan, B. B., Couper, D. J., Tielsch, J. M., Klein, B. E. K., & Hubbard, L. D. (2002) · JAMA · doi:10.1001/jama.287.9.1153 · Cited by 795
Wong, T. Y., Klein, R., Couper, D. J., Cooper, L. S., Shahar, E., Hubbard, L. D., Wofford, M. R., & Sharrett, A. R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06253-5 · Cited by 781
Stehouwer, C. D. A., Gall, M.-A., Twisk, J. W. R., Knudsen, E., Emeis, J. J., & Parving, H.-H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1157 · Cited by 652
Cited by
Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., Chasan-Taber, L., Albright, A. L., & Braun, B. (2010) · Diabetes Care · doi:10.2337/dc10-9990 · Cited by 1,955
Insulin resistance and hyperglycaemia in cardiovascular disease development
Laakso, M., & Kuusisto, J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.29 · Cited by 858
Self-citation(2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181eeb61c · Cited by 567
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 302
Arterial stiffness in diabetes mellitus
Prenner, S. B., & Chirinos, J. A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.023 · Cited by 313
Metadata
- Authors
- Juutilainen, A., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M.
- Affiliations
- University of Eastern Finland (FI)
- Department of Medicine, University of Turku, Turku, Finland
- Department of Medicine, University of Kuopio, Kuopio, Finland
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-02-01
- Volume
- 30
- Issue
- 2
- Pages
- 292-299
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2145578924
- Cited by
- 209
- References
- 44
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 2 · 2022: 10 · 2021: 10 · 2020: 11 · 2019: 8 · 2018: 13 · 2017: 8 · 2016: 10 · 2015: 7 · 2014: 11 · 2013: 11 · 2012: 17
- FWCI
- 19.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- diabetic retinopathy, type 2 diabetes, cardiovascular mortality, coronary heart disease mortality, all-cause mortality, sex differences, background retinopathy, proliferative retinopathy, diabetic microangiopathy, macroangiopathy, cardiovascular risk prediction
- MeSH terms
- Blood Pressure, Cardiovascular Diseases, Cholesterol, Coronary Disease, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diet, Diabetic, Diabetic Retinopathy, Diet, Female, Finland, Glomerular Filtration Rate, Humans, Hypertension, Hypoglycemic Agents, Male, Middle Aged, Predictive Value of Tests, Registries, Proportional Hazards Models, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women. https://app.cochat.ai/papers/10.2337/dc06-1747
- The paper
- Juutilainen, A., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (2007). Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women. Diabetes Care. https://doi.org/10.2337/dc06-1747
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.